相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Involvement of Breast Cancer Resistance Protein (BCRP1/ABCG2) in the Bioavailability and Tissue Distribution of trans-Resveratrol in Knockout Mice
Irene Alfaras et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Multidrug Resistance Proteins Restrain the Intestinal Absorption of trans-Resveratrol in Rats
M. Emilia Juan et al.
JOURNAL OF NUTRITION (2010)
Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC
M. Emilia Juan et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Resveratrol bioavailability and toxicity in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
Radojka M. Savic et al.
AAPS JOURNAL (2009)
Resveratrol: Its Biologic Targets and Functional Activity
Shazib Pervaiz et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review)
Fabrizia Brisdelli et al.
CURRENT DRUG METABOLISM (2009)
Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
Teresa Nunes et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
Luis Almeida et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol
Koen van de Wetering et al.
MOLECULAR PHARMACOLOGY (2009)
Metabolism and disposition of resveratrol in the isolated perfused rat liver:: Role of Mrp2 in the biliary excretion of glucuronides
Alexandra Maier-Salamon et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes
Allan Lancon et al.
DRUG METABOLISM AND DISPOSITION (2007)
Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells
Nicole Sabolovic et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2006)
PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2005)
Toxicogenomics of resveratrol in rat liver
V Hebbar et al.
LIFE SCIENCES (2005)
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene
S Sale et al.
BRITISH JOURNAL OF CANCER (2004)
Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model
JF Marier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver
C De Santi et al.
XENOBIOTICA (2000)
Resveratrol is absorbed in the small intestine as resveratrol glucuronide
G Kuhnle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
